Overview Fundamentals API Earnings EOD API Sample Code Pricing

Anebulo Pharmaceuticals Inc (ANEB NASDAQ) stock market data APIs

$2.22 0.02(0.9%) as of July 19, 2024
Price chart is built with Anychart

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

Anebulo Pharmaceuticals Inc Financial Data Overview

57 053 K
25 933 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ANEB',
Type: 'Common Stock',
Name: 'Anebulo Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZWY5GC8',
CIK: '1815974',
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: '2021-05-07',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Anebulo Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Anebulo Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast -0.12

Get Anebulo Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?